Full Answer
ICD 10 Code I82.81. I82.81 is a non-billable ICD 10 code for Embolism and thrombosis of superficial veins of lower extremities. It should not be used for HIPAA-covered transactions as a more specific code is available to choose from below.
Acute embolism and thrombosis of right popliteal vein. I82.431 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM I82.431 became effective on October 1, 2018.
Saphenous vein thrombosis and superficial vein thrombosis in general were widely regarded as benign conditions for decades. However, modern data suggests that saphenous vein thrombosis may actually co-exist at the time of diagnosis with deep vein thrombosis or even pulmonary embolism.
Short description: Embolism and thrombosis of superficial veins of low extrm The 2021 edition of ICD-10-CM I82.81 became effective on October 1, 2020. This is the American ICD-10-CM version of I82.81 - other international versions of ICD-10 I82.81 may differ.
ICD-10-CM Code for Embolism and thrombosis of superficial veins of lower extremities I82. 81.
A superficial venous thrombosis, sometimes called VTE, is a blood clot existing in a vein close to the surface of the skin, commonly in the arms or legs. Unlike deep vein thrombosis, or DVT, a superficial venous thrombosis is less likely to cause serious complications but it can still cause pain and discomfort.
Objective: Acute superficial vein thrombosis (SVT) of the axial veins, such as the great saphenous vein (GSV), is a common clinical condition that carries with it significant risk of propagation of thrombus, recurrence, and, most concerning, subsequent venous thromboembolism (VTE).
Abstract. Background: Isolated great saphenous vein thrombus (GSVT) is generally regarded as benign, and treatment is heterogeneous. Complications include thrombus propagation, new saphenous vein thrombosis, deep vein thrombosis (DVT), pulmonary embolism (PE), and symptom persistence.
Great Saphenous Vein (GSV) – The GSV is the large superficial vein of the leg and the longest vein in the entire body. It can be found along the length of the lower limb, returning blood from the thigh, calf, and foot to the deep femoral vein at the femoral triangle.
Superficial vein thrombosis (SVT) refers to a blood clot in a vein near the surface, deep vein thrombosis (DVT) is a clot in a deep vein in the body, usually in the leg. Superficial vein thrombosis can present as pain and inflammation while deep clots can travel to the lungs and cause a pulmonary embolism.
"The great saphenous vein is the major superficial vein of the medial leg and thigh. It is the longest vein in the human body, extending from the top of the foot to the upper thigh and groin.
A saphenous vein is a vein in the leg that drains blood out of the leg and back to the heart. Each leg has a great saphenous vein, which travels along the front of the leg, and a small saphenous vein (also called the lesser saphenous vein), which travels along the back of the calf.
SVT in the superficial axial veins (great saphenous vein or small saphenous vein) is generally considered to warrant aggressive treatment with low molecular weight heparin to prevent extension into the deep venous system, particularly if the SVT is close to the junction with the common femoral or popliteal veins.
Blood Clot in the Great Saphenous Vein A blood clot in the GSV can often be identified by a warm, tender, or aching feeling in the leg area. In some cases, it can also cause swelling.
Clinical points Varicose veins: The small saphenous vein is a superficial vein. The deep veins (posterior tibial, anterior tibial, fibular, popliteal, femoral) are separated from the superficial veins by a series of valves.
The great saphenous vein is the largest vein of the human body. It is also known as the long saphenous vein. The great saphenous vein starts from the medial marginal vein of foot, runs superficially along the length of the lower limb, to finally empty into the femoral vein.
A thrombus that completely obstructs the flow of blood through a vessel is known as an occlusive thrombus, and can result in the death of tissue supplied by the obstructed vessel.
DVT treatment options include: Blood thinners. These medicines, also called anticoagulants, help prevent blood clots from getting bigger. Blood thinners reduce the risk of developing more clots.
For superficial thrombophlebitis, your doctor might recommend applying heat to the painful area, elevating the affected leg, using an over-the-counter nonsteroidal anti-inflammatory drug (NSAID) and possibly wearing compression stockings. The condition usually improves on its own.
Blood clots in veins close to the skin's surface usually are not serious and often can be treated at home. Sometimes superficial thrombophlebitis spreads to a deeper vein (deep vein thrombosis, or DVT). These deeper clots can be serious, even life-threatening.
The ICD code I828 is used to code Paget-Schroetter disease. Paget–Schroetter disease, also known as Paget–von Schrötter disease, is a form of upper extremity deep vein thrombosis (DVT), a medical condition in which blood clots form in the deep veins of the arms.
I82.81. Non-Billable means the code is not sufficient justification for admission to an acute care hospital when used a principal diagnosis. Use a child code to capture more detail. ICD Code I82.81 is a non-billable code.
There are too many ICD 10 codes for vein related diagnosis to list here. For example, just for varicose vein related diagnosis, there are roughly 30 ICD 10 codes. However, some of the primary diagnosis codes we use in our practice are as follows:
A CPT code is a 5 digit number code that describes every procedure or medical service that exists. CPT codes are defined and maintained by the American Medical Association. One of the main uses of these codes are for billing. Whenever a doctor performs a service or procedure, she or he chooses the most appropriate CPT codes.
These include predominantly NSAIDs, graded compression stockings and warm compresses. It is important to note that these measures provide symptomatic relief, however do not reduce the risk of propagation of the clot. Surgical ligation is reserved for patients with frequent recurrences or for cosmetic reasons. When the choice is made not to anticoagulate close surveillance is usually recommended by serial duplex ultrasound examinations.
First, are the risk factors that are common for any venous thrombosis. Examples include thrombophilia, malignancy, age, immobility etc. There is evidence to suggest these factors are not rarely present in patients with saphenous vein thrombosis. A second group of risk factors are unique to saphenous vein thrombosis. Examples include post-ligation or post-EVLT. This is known as EHIT. Venous insufficiency is a risk factor for superficial vein thrombosis. However, when the thrombosis occurs outside of the varicose vein or in a vein in which there is no stagnant blood flow, other causes should be though of.
To date there is no clear recommendation as to the treatment of saphenous vein thrombosis. The latest ACCP guidelines suggests 45 days of prophylactic dose fondaparinux for ‘extensive’ lower extremity thrombosis. They are relying on the CALISTO study. One should note that the CALISTO investigators excluded many patients otherwise common in clinical practice such as patients with renal failure, malignancy, proven hypercoagulability and those with prior venous thromboembolism. Adequately, the level of this recommendation is quite weak. A 2012 mini-review published in the Annals of Internal Medicine echoed this finding pointing out that fondaparinux has to be given to 88 patients with saphenous vein thrombosis to prevent one deep vein thrombosis. A cheaper alternative may be low molecular weight heparin. However current data is confusing. The most problematic piece of information regarding low molecular weight heparin and saphenous vein thrombosis is that the deep vein thrombosis reducing effect may not be long-lived, as opposed to fondaparinux. On the other hand shorter duration of treatment was given. This data was again summarized without much change in a 2012 Cochrane database review of the matter.
As a side note, superficial vein thrombosis may be used to describe thrombosis in superficial veins in non-limb locations such as the abdominal wall. It is important not to dismiss these clots. While they appear to be superficial at first glance, these clots may actually represent extension from a deep vein thrombosis such as the inferior vena cava or a sign of Trousseau Syndrome.
There is no evidence to prove this approach is right. Proponents state that as the rate of clot progression is unpredictable, this approach is safe.
Modern data suggests that saphenous vein thrombosis can propagate. Furthermore, there is data to suggest that saphenous vein thrombosis actually commonly co-presents with deep vein thrombosis or even pulmonary embolism. These are most likely not rare occurrences and have been described as prevalent as 53%.
Historically saphenous vein thrombosis was regarded as a benign condition. It was a disease treated by surgeons and encountered mainly in immobilized post-surgical patients. However there is data to suggest otherwise. Modern data suggests that saphenous vein thrombosis can propagate.
I82.81 is a non-billable ICD-10 code for Embolism and thrombosis of superficial veins of lower extremities. It should not be used for HIPAA-covered transactions as a more specific code is available to choose from below.
Billable - I82.811 Embolism and thrombosis of superficial veins of right lower extremity
Cutting through the skin or mucous membrane and any other body layers necessary to expose the site of the procedure
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach and visualize the site of the procedure